Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 4.10T | 3.87T | 3.54T | 2.80T | 2.19T |
Gross Profit | 1.32T | 1.21T | 1.04T | 779.58B | 581.05B |
EBITDA | 825.44B | 787.00B | 658.49B | 473.14B | 309.67B |
Net Income | 439.61B | 393.43B | 326.40B | 224.93B | 106.24B |
Balance Sheet | |||||
Total Assets | 5.77T | 5.64T | 4.88T | 4.35T | 3.78T |
Cash, Cash Equivalents and Short-Term Investments | 385.57B | 403.18B | 289.98B | 316.67B | 243.13B |
Total Debt | 1.22T | 1.27T | 1.12T | 1.01T | 965.85B |
Total Liabilities | 2.43T | 2.44T | 2.20T | 1.99T | 1.77T |
Stockholders Equity | 3.17T | 3.03T | 2.54T | 2.23T | 1.91T |
Cash Flow | |||||
Free Cash Flow | 311.31B | 231.83B | 22.94B | 138.01B | 172.58B |
Operating Cash Flow | 517.17B | 434.78B | 206.47B | 300.97B | 354.13B |
Investing Cash Flow | -210.67B | -204.42B | -169.52B | -143.57B | -163.06B |
Financing Cash Flow | -321.42B | -122.04B | -66.61B | -93.87B | -199.67B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $30.03B | 10.57 | 13.96% | 2.66% | 0.63% | 7.62% | |
77 Outperform | $8.01B | 13.30 | 15.24% | 1.64% | 5.95% | -10.59% | |
70 Outperform | $190.84B | 19.77 | 55.67% | 1.39% | -5.58% | -7.37% | |
70 Outperform | $137.47B | 24.56 | 24.07% | 1.29% | -22.26% | -37.83% | |
66 Neutral | $16.67B | 16.06 | 13.26% | 1.87% | -21.99% | -52.11% | |
65 Neutral | $10.90B | 15.41 | 5.26% | 1.89% | 3.11% | -26.85% | |
58 Neutral | $8.08B | 46.40 | -13.60% | 1.07% | -23.02% | -152.78% |